Related Funds
Fund Name | Location |
Amorchem | Canada, Montréal, Quebec |
Artha Impact | Switzerland, Zürich, Zurich |
Belay Capital | Australia, New South Wales, Sydney |
Cascadia Pacific | Kirkland, United States, Washington |
Common Angels Fund | - |
D2 Garage Japan | Hokkaido Prefecture, Japan, Sapporo |
Endo Investors | California, Los Angeles, United States |
eshbol | HaMerkaz, Israel, Kfar Malal |
Gongye Yuanqu Investment | China, Jiaxing, Zhejiang |
Huda Associates | England, London, United Kingdom |
Infinion Biopharma | Ahmedabad, Gujarat, India |
Kunlun | Beijing, Beijing, China |
New General Market Ventures | New City, New York, United States |
RLC Ventures | England, London, United Kingdom |
Sage Venture Capital | - |
ServiceMaster | Memphis, Tennessee, United States |
Takahata Precision | Japan, Tokyo |
Welkin Capital Management | China, Hong Kong, Hong Kong Island |
WM Motor | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
IsomAb | $10M | 20 Feb 2024 | Nottingham, Nottinghamshire, United Kingdom | ||
Delta g | $2M | 05 Jul 2023 | Birmingham, West Midlands, United Kingdom | ||
Scarlet Therapeutics | 23 May 2023 | Bristol, South West, United Kingdom | |||
VyperCore | $4M | 19 Apr 2023 | Cambridge, Cambridgeshire, United Kingdom | ||
Kelpi | $4M | 01 Feb 2023 | Bath, Bath and North East Somerset, United Kingdom | ||
IsomAb | 01 Jan 2023 | Nottingham, Nottinghamshire, United Kingdom | |||
Nebu~Flow | $2M | 10 May 2022 | Glasgow City, Glasgow, United Kingdom | ||
OxDX | $3M | 15 Feb 2022 | Oxford, England, United Kingdom | ||
Imophoron | $5M | 07 Oct 2021 | Bristol, England, United Kingdom |
– Forefront RF is a fabless semiconductor company based in Cambridge, UK.
– The company raised £1.5m in funding.
– The round was led by Science Creates Ventures with participation from Foresight Williams Technology, BGF, and The Cambridge Angels.
– The new investment will be used to expand the team and accelerate the launch of its products.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
IsomAb | $10M | 20 Feb 2024 | Nottingham, Nottinghamshire, United Kingdom | ||
Delta g | $2M | 05 Jul 2023 | Birmingham, West Midlands, United Kingdom | ||
Scarlet Therapeutics | 23 May 2023 | Bristol, South West, United Kingdom | |||
VyperCore | $4M | 19 Apr 2023 | Cambridge, Cambridgeshire, United Kingdom | ||
Kelpi | $4M | 01 Feb 2023 | Bath, Bath and North East Somerset, United Kingdom | ||
IsomAb | 01 Jan 2023 | Nottingham, Nottinghamshire, United Kingdom | |||
Nebu~Flow | $2M | 10 May 2022 | Glasgow City, Glasgow, United Kingdom | ||
OxDX | $3M | 15 Feb 2022 | Oxford, England, United Kingdom | ||
Imophoron | $5M | 07 Oct 2021 | Bristol, England, United Kingdom |